You must be logged in to post a comment.
The “Nonproprietary Naming of Biological Products” draft guidance was published by the Food and Drug Administration (FDA) in August 2015 […]
Dual branding in the pharmaceutical industry refers to a marketing strategy where a single product is marketed under two different […]
As of today, 13 novel drug names have been approved by the FDA in 2023. And of those 13 names […]
In 2025, there were approximately 144 brand names approved by the FDA (between FDA-CDER and FDA-CBER). Alexa Lash, Brand Institute’s […]
